Claire Emson
Impact in
- Immunology and Allergy top 1%
- Allergic Rhinitis and Sensitization
- Immunology top 2%
- IL-33, ST2, and ILC Pathways
- Immune Cell Function and Interaction
Papers in
-
- Allergic Rhinitis and Sensitization 7
- Genetics 10
- Chronic Lymphocytic Leukemia Research 9
- Co-authors
- Andrew N. J. McKenziePadraic G. FallonGrahame J. McKenzieRichard K. GrencisSarah E. BellScott TurnerHelen E. JolinPhilip Smith
- Journals
- Blood (5 papers)The Journal of Experimental Medicine (3 papers)The Journal of Immunology (3 papers)Journal of Allergy and Clinical Immunology (2 papers)Immunity (2 papers)
- Partner nations
- United StatesUnited KingdomSweden
In The Last Decade
Claire Emson
43 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 107
- Immunology and Allergy 544
- Immunology 1.2k
- Physiology 1.1k
- Otorhinolaryngology 170
- Genetics 332
Countries citing papers authored by Claire Emson
This map shows the geographic impact of Claire Emson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire Emson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire Emson more than expected).
Fields of papers citing papers by Claire Emson
This network shows the impact of papers produced by Claire Emson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire Emson. The network helps show where Claire Emson may publish in the future.
Co-authors
The 25 scholars most cited alongside Claire Emson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 53 | |
| 2 | 2023 | 27 | |
| 3 | Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trial Hit paper breakdown → | 2021 | 205 |
| 4 | 2020 | 25 | |
| 5 | 2017 | 9 | |
| 6 | 2017 | 69 | |
| 7 | 2017 | 88 | |
| 8 | 2017 | 26 | |
| 9 | 2016 | 75 | |
| 10 | 2015 | 45 | |
| 11 | 2014 | 9 | |
| 12 | 2013 | 80 | |
| 13 | 2011 | 129 | |
| 14 | 2011 | 14 | |
| 15 | 2010 | 11 | |
| 16 | 2002 | 280 | |
| 17 | 2001 | 68 | |
| 18 | 2000 | 129 | |
| 19 | 1998 | 156 | |
| 20 | 1996 | 4 |
About Claire Emson
Claire Emson is a scholar working on Immunology and Allergy, Genetics, Immunology, Physiology and Otorhinolaryngology, having authored 44 papers that have together received 3.1k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (15 papers), Chronic Lymphocytic Leukemia Research (9 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), Allergic Rhinitis and Sensitization (7 papers), IL-33, ST2, and ILC Pathways (5 papers), Lymphoma Diagnosis and Treatment (4 papers), Immunodeficiency and Autoimmune Disorders (3 papers) and Chronic Myeloid Leukemia Treatments (3 papers). The work is most often cited by research in Immunology and Allergy (544 citations), Immunology (1.2k citations), Physiology (1.1k citations), Otorhinolaryngology (170 citations) and Genetics (332 citations). Claire Emson has collaborated with scholars based in United States, United Kingdom and Sweden. Frequent co-authors include Andrew N. J. McKenzie, Padraic G. Fallon, Grahame J. McKenzie, Richard K. Grencis, Sarah E. Bell, Scott Turner, Helen E. Jolin, Philip Smith, Marc K. Hellerstein and Gérard Zurawski. Their work appears in journals such as Blood, The Journal of Experimental Medicine, The Journal of Immunology, Journal of Allergy and Clinical Immunology and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.